Amneal Pharmaceuticals, Inc. (AMRX) insider trading.
In Q3 2026, insiders at Amneal Pharmaceuticals, Inc. reported 14 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $7.2M.
- Transactions
- 14
- Purchases (P)
- 0
- Sales (S)
- 4
- Net shares, P minus S
- -413,016
- Insiders
- 9
- Last filed
- 2026-09-21
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Buchi J Kevin | Director | 3 | 0 | 0 |
| Boyer Andrew S | Officer · Executive Vice President | 2 | 0 | 0 |
| Kiely John | Director | 2 | 0 | 1 |
| Daly Jason B. | Officer · EVP, Chief Legal Officer | 2 | 0 | 2 |
| Shah Nikita | Officer · Executive Vice President | 1 | 0 | 1 |
| Patel Tushar Bhikhubhai | TenPercentOwner | 1 | 0 | 0 |
| Patel Chirag K. | Director, Officer · President & Co-CEO | 1 | 0 | 0 |
| Patel Gautam | Director | 1 | 0 | 0 |
| Patel Chintu | Director, Officer · Co-CEO | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | Buchi J Kevin | G (D) | 20,445 | $0 | 75,077 | Form 4 |
| 2026-09-11 | Buchi J Kevin | M (A) | 20,445 | $14.45 | 95,522 | Form 4 |
| 2026-09-01 | Boyer Andrew S | G (D) | 80,000 | $0 | 193,646 | Form 4 |
| 2026-08-21 | Boyer Andrew S | G (D) | 152,426 | $0 | 273,646 | Form 4 |
| 2026-08-13 | Kiely John | S (D) | 50,000 | $17.64 | 210,252 | Form 4 |
| 2026-08-13 | Kiely John | G (D) | 10,000 | $0 | 200,252 | Form 4 |
| 2026-08-12 | Daly Jason B. | S (D) | 210,000 | $17.4 | 35,171 | Form 4 |
| 2026-08-12 | Shah Nikita | S (D) | 146,403 | $17.51 | 253,390 | Form 4 |
| 2026-08-11 | Buchi J Kevin | M (D) | 168,573 | $17.18 | 93,499 | Form 4 |
| 2026-08-11 | Daly Jason B. | S (D) | 6,613 | $17.7 | 245,171 | Form 4 |
| 2026-08-10 | Patel Tushar Bhikhubhai | A (A) | 12,763,469 | — | 61,341,678 | Form 4 |
| 2026-08-10 | Patel Chirag K. | A (A) | 6,381,734 | — | 6,381,734 | Form 4 |
| 2026-08-10 | Patel Gautam | A (A) | 283,632 | — | 283,632 | Form 4 |
| 2026-08-10 | Patel Chintu | A (A) | 6,381,734 | — | 6,381,734 | Form 4 |
Transaction codes in this quarter
Get AMRX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1723128&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · AMRX company page · Amneal Pharmaceuticals, Inc. on SEC.gov
Questions
Are insiders buying or selling Amneal Pharmaceuticals, Inc. (AMRX)?
In Q3 2026, insiders at Amneal Pharmaceuticals, Inc. reported 14 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $7.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Amneal Pharmaceuticals, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/amrx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.